Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update

Roche Holding AG (OTCMKTS:RHHBY) was the recipient of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 2,068,200 shares, a drop of 45.0% from the January 31st total of 3,761,500 shares. Based on an average daily trading volume, of 2,515,400 shares, the short-interest ratio is currently 0.8 days.

Roche Trading Up 0.7 %

Roche stock opened at $41.74 on Friday. Roche has a fifty-two week low of $29.20 and a fifty-two week high of $42.43. The firm’s fifty day moving average price is $38.24 and its 200-day moving average price is $38.42. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26.

Analyst Ratings Changes

A number of brokerages recently commented on RHHBY. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Morgan Stanley initiated coverage on shares of Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating for the company. Finally, UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Roche currently has an average rating of “Hold”.

Institutional Investors Weigh In On Roche

Hedge funds have recently added to or reduced their stakes in the company. Altrius Capital Management Inc increased its position in shares of Roche by 0.3% during the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after purchasing an additional 603 shares during the last quarter. Kornitzer Capital Management Inc. KS grew its position in Roche by 1.3% during the third quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock valued at $5,490,000 after acquiring an additional 1,798 shares during the last quarter. Bard Financial Services Inc. raised its stake in shares of Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after acquiring an additional 30,350 shares in the last quarter. Diversified Trust Co lifted its holdings in shares of Roche by 1.2% in the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after acquiring an additional 711 shares during the last quarter. Finally, Hantz Financial Services Inc. boosted its stake in shares of Roche by 0.9% in the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after purchasing an additional 305 shares in the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.